Vaccine Hesitancy Persists
With three COVID-19 vaccines on the market, retailers continue to navigate reluctance among their workforce to get the shots.
March 01, 2021
WASHINGTON, D.C. The U.S. Food and Drug Administration approved Johnson & Johnson’s single-dose Janssen COVID-19 Vaccine last week, paving the way for distribution of a third preventative treatment in the United States.
“The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic,” said Acting FDA Commissioner Janet Woodcock, M.D. The vaccine is available for individuals 18 years of age and older.